CXCL9 and cancer: Upregulation of these genes was confirmed by qPCR (Supplementary Fig. S6A), and ELISA demonstrated that secretion of CXCL9 and CXCL10 was strongly increased in cancer cells co-treated with TAK-243 and IFN-γ (Supplementary Fig. S6B).